388110login-checkPioneering protocol could enable transplant recipients to thrive without antirejection drugs |
Performing human-organ transplants without the necessity for a lifetime regimen of immunosuppressive drugs has been an enduring goal for transplantation medicine.
Now, a new protocol being implemented at UCLA Health with select living-donor kidney-transplant patients is bringing that dream closer to reality.
“It is the Holy Grail,” says renal transplant surgeon Jeffrey Veale, MD, who has led the pioneering effort to develop the protocol. Read more.
388110login-checkPioneering protocol could enable transplant recipients to thrive without antirejection drugs |